|
Summary of Segment Net Revenues, Segment Operating Income Loss and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Detail) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 12 Months Ended | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2013
|
Sep. 30, 2013
|
Jun. 30, 2013
|
Mar. 31, 2013
|
Dec. 31, 2012
|
Sep. 30, 2012
|
Jun. 30, 2012
|
Mar. 31, 2012
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Patient service operating revenues | $ 3,063,209 | $ 2,999,586 | $ 2,871,673 | $ 2,829,582 | $ 2,477,853 | $ 1,945,888 | $ 1,913,006 | $ 1,849,533 | $ 8,307,195 | $ 7,351,902 | $ 6,470,540 | |||||||||
| Less: Provision for uncollectible accounts | (293,546) | (235,218) | (190,234) | |||||||||||||||||
| Total net operating revenues | 11,764,050 | 8,186,280 | 6,731,806 | |||||||||||||||||
| Net patient service revenues | 8,013,649 | 7,116,684 | 6,280,306 | |||||||||||||||||
| Other revenues | 763,086 | 588,260 | 406,367 | |||||||||||||||||
| Contingent earn-out obligation adjustment | 56,977 | |||||||||||||||||||
| Corporate support costs | (65,041) | [1] | (52,457) | [1] | (47,051) | [1] | ||||||||||||||
| Transaction expenses | (30,753) | |||||||||||||||||||
| Operating income | 484,179 | 377,074 | 522,020 | 166,861 | 388,056 | 340,885 | 247,261 | 320,882 | 1,550,134 | 1,297,084 | 1,154,713 | |||||||||
| Debt expense | (429,943) | (288,554) | (241,090) | |||||||||||||||||
| Debt refinancing and redemption charges | (10,963) | |||||||||||||||||||
| Other income | 4,787 | 3,737 | 2,982 | |||||||||||||||||
| Consolidated income from continuing operations before income taxes | 380,020 | 270,766 | 412,550 | 61,642 | 282,162 | 271,210 | 187,392 | 260,540 | 1,124,978 | 1,001,304 | 916,605 | |||||||||
|
U.S. dialysis and related lab services
|
||||||||||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Patient service operating revenues | 8,032,772 | 7,316,818 | 6,473,952 | |||||||||||||||||
| Less: Provision for uncollectible accounts | (281,146) | (233,580) | (190,234) | |||||||||||||||||
| Net patient service revenues | 7,751,626 | 7,083,238 | 6,283,718 | |||||||||||||||||
| Other revenues | 12,600 | [2] | 11,447 | [2] | 11,019 | [2] | ||||||||||||||
|
HealthCare Partners (HCP)
|
||||||||||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Patient service operating revenues | 2,920,214 | 419,431 | ||||||||||||||||||
| Net patient service revenues | 220,251 | 34,407 | ||||||||||||||||||
| Other revenues | 55,723 | 23,552 | ||||||||||||||||||
|
Other-ancillary services and strategic initiatives
|
||||||||||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Patient service operating revenues | 67,351 | 61,906 | 45,133 | |||||||||||||||||
| Net patient service revenues | 75,852 | 16,824 | 7,730 | |||||||||||||||||
| Other revenues | 694,763 | 553,261 | 395,347 | |||||||||||||||||
|
Operating Segments
|
||||||||||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Total net operating revenues | 11,812,296 | 8,214,547 | 6,748,743 | |||||||||||||||||
| Operating income | 1,558,198 | [3] | 1,380,294 | [3] | 1,201,764 | [3] | ||||||||||||||
|
Operating Segments | U.S. dialysis and related lab services
|
||||||||||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Patient service operating revenues | 7,998,692 | 7,299,032 | 6,462,811 | |||||||||||||||||
| Total net operating revenues | 7,764,226 | 7,094,685 | 6,294,737 | |||||||||||||||||
| Operating income | 1,211,540 | [3] | 1,378,241 | [3] | 1,235,869 | [3] | ||||||||||||||
|
Operating Segments | HealthCare Partners (HCP)
|
||||||||||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Patient service operating revenues | 2,919,964 | 419,431 | ||||||||||||||||||
| Total net operating revenues | 3,196,188 | 477,390 | ||||||||||||||||||
| Operating income | 385,253 | [3] | 66,930 | [3] | ||||||||||||||||
|
Operating Segments | Other-ancillary services and strategic initiatives
|
||||||||||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Total net operating revenues | 851,882 | 642,472 | 454,006 | |||||||||||||||||
| Operating income | (38,595) | [3] | (64,877) | [3] | (34,105) | [3] | ||||||||||||||
|
Intersegment Elimination
|
||||||||||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Total net operating revenues | (48,246) | (28,267) | (16,937) | |||||||||||||||||
|
Intersegment Elimination | U.S. dialysis and related lab services
|
||||||||||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Patient service operating revenues | (34,080) | (17,786) | (11,141) | |||||||||||||||||
|
Intersegment Elimination | HealthCare Partners (HCP)
|
||||||||||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Patient service operating revenues | 250 | |||||||||||||||||||
|
Intersegment Elimination | Other-ancillary services and strategic initiatives
|
||||||||||||||||||||
| Segment Reporting Information [Line Items] | ||||||||||||||||||||
| Total net operating revenues | $ (13,916) | $ (10,481) | $ (5,796) | |||||||||||||||||
|
||||||||||||||||||||